All Articles

New data reveals a novel cancer drug shrinks brain metastases in over half of small cell lung cancer patients, offering hope where options are scarce.

MLB legend Darryl Strawberry shares his recovery journey, highlighting Gaudenzia's fight against addiction amidst a regional public health crisis.

With $10M in new funding, Creao AI is building a 'closed-loop' system where AI builds and runs its own tools, promising one person the power of a team.

A new AI platform claims to find, analyze, and negotiate property deals with minimal human input, blurring the line between support tool and transaction agent.

A new platform watches individual tumor cells to link behavior with biology, offering a powerful tool against treatment resistance in cancers like glioblastoma.

Premier agency VIPs Entertainment is changing how elite events are staffed, launching a new digital platform to streamline booking high-end bands and DJs.

Hainan's 2026 consumer expo showcases flying cars and global brands, all powered by its new, ambitious free trade port policies that are reshaping trade.

A $300M tugboat deal pushes Woodside's investment in Louisiana past $1 billion, boosting the state's maritime industry and its role in global energy.

While national reading scores falter, a Mississippi school sees 63% of its most challenged readers make gains. Here's how they are doing it.

Aviation Capital Group seeks a new financial chief as Craig Segor steps down after a successful four-year tenure, leaving the firm in a strong position.

Genomic Prediction reappoints its founding CEO, Laurent Tellier, signaling a push for innovation amid ethical debates and questions about its market standing.

Interim trial data shows IPH5201 plus durvalumab yields pathological complete response rates up to 50%, far surpassing current standards for resectable NSCLC.

With new EU eco-design rules looming, Glimpact's funding from Sparkalis signals a major shift toward data-driven sustainability in the agri-food industry.

Presented at AACR 2026, first-in-class antibody IMT-009 shows clinical benefit in tough cancers, potentially paving the way for a new precision therapy.

Interfaith America releases a new guide to help diverse religious communities counter polarization and ensure a free, fair, and peaceful midterm election.

A minor increase in pension transfer costs does little to cool a hot market, as companies continue to offload risk in a multi-billion dollar trend.

With 60,000+ attendees and 650+ events, SF Climate Week 2026 questions if massive, decentralized gatherings can truly accelerate climate solutions.

With a key public listing and backing from mining giant Glencore, Errington Metals is set to unlock the underexplored potential of the Sudbury Basin.

New data on ATX-295 reveals a potent attack on unstable tumors, guided by an AI biomarker that could change how we select patients for treatment.

Newcomer Capital-FORCE makes a strategic entry into the competitive ETF space by acquiring two established IBD-branded funds from Innovator.